Subscribe to our Email Alerts

Island Pharmaceuticals
  • About Us
    • Island at a glance
    • Board
    • Key Management
    • Scientific Advisory Board
    • Collaborations
  • Science
    • About ISLA-101
    • Scientific Publications
    • Drug repurposing and benefits
    • Disease and drug terms explained
  • Investor Centre
    • Investor Welcome
      • Clinical programme
    • ASX Announcements
    • Presentations
    • Prospectus
    • Financial Reports
    • Share Price Information
    • Shareholder Services
    • Investor Fact Sheet
    • Corporate Governance
    • Corporate Directory
    • International Investors
    • Research Coverage
    • AGM
  • Media
    • News
    • IslandWatch Newsletter
  • Contact
    • Contact Us
    • Subscribe for Email Alerts
Investor Centre
Investor Centre > Research Coverage
  • Investor Welcome
    • Clinical programme
  • ASX Announcements
  • Presentations
  • Prospectus
  • Financial Reports
  • Share Price Information
  • Shareholder Services
  • Investor Fact Sheet
  • Corporate Governance
  • Corporate Directory
  • International Investors
  • Research Coverage
  • AGM

Research Coverage


 
29-Apr-2025    Battling Flavivirus: ISLA-101 Making Leaps Beyond Discovery  
 
29-Apr-2025    Pitt Street Research: Key results coming soon  
 
5-Dec-2024    Pitt Street Research: Initial Phase II results look good  
 
15-Oct-2024    Pitt Street Research: A company-defining 12 months lie ahead  
 
8-Apr-2024    MST Access: Data to confirm PEACH trial  
 
6-Feb-2024    MST Access: SAD Trial Cohort 3  
 
20-Nov-2023    MST Access: Clinical program starts  
 
12-Oct-2023    MST Access: Clinical program to start  
 
11-Jan-2023    MST Access: IND submission starts the clock  
 
22-Dec-2022    MST Access: Phase 2a trial on track for early CY23  
 
25-Nov-2022    MST Access: Trial to start early CY23  
 
27-Jul-2022    MST Access initiates research coverage on Island Pharmaceuticals  
 

NOTICE

It has come to the company's attention that unauthorised individuals may be falsely claiming to represent Island Pharmaceuticals Limited in employment offers and recruitment communications. Please be advised that all legitimate employment opportunities are advertised through official company channels, the company's social media channels and via authorised recruitment partners.

Island Pharmaceuticals Limited will never request payment, personal financial information, or conduct interviews via unofficial platforms. If you receive a suspicious message or offer, please report it to us immediately at henry.jordan@sdir.com.au

Your safety and security are important to us.

Kind regards,
Island Pharmaceuticals Limited

Quick Links

Contact Us

Island Pharmaceuticals
Suite 201, 697 Burke Road
Camberwell, Victoria 3124

info@islandpharmaceuticals.com

www.islandpharmaceuticals.com

Email Alerts

Which of the following group do you best fit?

 

Follow Us

Follow Us

Site Map Privacy Search
Copyright © Island Pharmaceuticals
Site Map Privacy Search
Site by